Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
By Lori Mosca, Emelia J. Benjamin, Kathy Berra, J. Bezanson, R. Dolor, D. Lloyd‐Jones, L. Newby, Ileana L. Piña, Véronique L. Roger, Leslee J. Shaw and 27 more. Circulation, 2011
1,033 citations recorded by the source corpus.
Substantial progress has been made in the awareness, treatment, and prevention of cardiovascular disease (CVD) in women since the first women-specific clinical recommendations for the prevention of CVD were published by the American Heart Association (AHA) in 1999.1 The myth that heart disease is a “man’s disease” has been debunked; the rate of public awareness of CVD as the leading cause of death among US women has increased from 30% in 1997 to 54% in 2009.2 The age-adjusted death rate resulting from coronary heart disease (CHD) in females, which accounts for about half of all CVD deaths in women, was 95.7 per 100 000 females in 2007, a third of what it was in 1980.3,4 Approximately 50% of this decline in CHD deaths has been attributed to reducing major risk factors and the other half to treatment of CHD including secondary preventive therapies.4 Major randomized controlled clinical trials such as the Women’s Health Initiative have changed the practice of CVD prevention in women over the past decade.5 The investment in combating this major public health issue for women has been significant, as have the scientific and medical achievements.
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/6fa06a3fe60508c5d586f37d951860d73810b238
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.